E-MYCIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover E-mycin, and when can generic versions of E-mycin launch?
E-mycin is a drug marketed by Arbor Pharms Inc and Pharmacia And Upjohn and is included in two NDAs.
The generic ingredient in E-MYCIN is erythromycin ethylsuccinate. There are one hundred and three drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for E-mycin
A generic version of E-MYCIN was approved as erythromycin ethylsuccinate by AZURITY on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for E-MYCIN?
- What are the global sales for E-MYCIN?
- What is Average Wholesale Price for E-MYCIN?
Summary for E-MYCIN
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 103 |
| Patent Applications: | 5,714 |
| DailyMed Link: | E-MYCIN at DailyMed |
US Patents and Regulatory Information for E-MYCIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Arbor Pharms Inc | E-MYCIN | erythromycin | TABLET, DELAYED RELEASE;ORAL | 060272-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pharmacia And Upjohn | E-MYCIN E | erythromycin ethylsuccinate | SUSPENSION;ORAL | 062198-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Arbor Pharms Inc | E-MYCIN | erythromycin | TABLET, DELAYED RELEASE;ORAL | 060272-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
